Design Therapeutics Enroling for Australian-based Clinical Trial

The pamphlet below has been produced by Design Therapeutics to support the forthcoming clinical trials now enroling for eligible Australian & New Zealand patients.

Next
Next

omav Early Access Program Not Impacted by PBAC Decision